Show simple item record

dc.contributor.authorSmits, Gaby
dc.contributor.authorStabell Benn, Christine
dc.contributor.authorWhittle, Hilton
dc.contributor.authorvan Binnendijk, Rob
dc.contributor.authorAaby, Peter
dc.contributor.authorvan der Klis, Fiona
dc.date.accessioned2018-11-20T09:37:49Z
dc.date.available2018-11-20T09:37:49Z
dc.date.issued2018-10-16
dc.identifier.citationMaternal measles antibodies and their influence on all-cause mortality following measles vaccination: an alternative to measure very low maternal antibody levels. 2018 Clin. Infect. Dis.en
dc.identifier.issn1537-6591
dc.identifier.pmid30329030
dc.identifier.doi10.1093/cid/ciy900
dc.identifier.urihttp://hdl.handle.net/10029/622291
dc.description.abstractIt was previously shown by hemagglutination inhibition that measles-vaccination in the presence of maternal measles antibodies was associated with reduced all-cause mortality. We confirmed this serological association using a multiplexed immunoassay as a sensitive alternative and estimated a threshold concentration (28.7 mIU/ml), that correlates with lower all-cause mortality (p=0.02).
dc.language.isoenen
dc.rightsinfo:eu-repo/semantics/closedAccessen
dc.titleMaternal measles antibodies and their influence on all-cause mortality following measles vaccination: an alternative to measure very low maternal antibody levels.en
dc.identifier.journalClin Infect Dis 2019; 68(10):1758-60en
html.description.abstractIt was previously shown by hemagglutination inhibition that measles-vaccination in the presence of maternal measles antibodies was associated with reduced all-cause mortality. We confirmed this serological association using a multiplexed immunoassay as a sensitive alternative and estimated a threshold concentration (28.7 mIU/ml), that correlates with lower all-cause mortality (p=0.02).


This item appears in the following Collection(s)

Show simple item record